Soleus Capital Management as of June 30, 2026
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 97 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Krystal Biotech (KRYS) | 12.0 | $349M | 939k | 371.67 | |
| Celcuity (CELC) | 6.1 | $178M | 1.7M | 104.62 | |
| Tg Therapeutics (TGTX) | 5.5 | $161M | 2.9M | 54.94 | |
| Insulet Corporation (PODD) | 5.5 | $160M | 1.0M | 152.25 | |
| Novocure Ord Shs (NVCR) | 5.2 | $150M | 9.9M | 15.15 | |
| United Therapeutics Corporation (UTHR) | 4.2 | $122M | 226k | 541.83 | |
| Inspire Med Sys (INSP) | 3.0 | $86M | 1.9M | 44.61 | |
| Rigel Pharmaceuticals (RIGL) | 2.5 | $72M | 1.8M | 39.12 | |
| Biosante Pharmaceuticals (ANIP) | 2.5 | $72M | 868k | 82.78 | |
| Beta Bionics (BBNX) | 2.4 | $69M | 4.4M | 15.67 | |
| Vericel (VCEL) | 2.2 | $65M | 1.5M | 44.49 | |
| Praxis Precision Medicines I Com New (PRAX) | 2.0 | $59M | 178k | 334.79 | |
| Geron Corporation (GERN) | 1.9 | $55M | 43M | 1.28 | |
| Alkermes SHS (ALKS) | 1.9 | $54M | 1.0M | 52.40 | |
| Erasca (ERAS) | 1.7 | $50M | 2.7M | 18.32 | |
| Neuropace (NPCE) | 1.6 | $46M | 2.9M | 15.89 | |
| Progyny (PGNY) | 1.6 | $46M | 1.6M | 28.83 | |
| Indivior Pharmaceuticals (INDV) | 1.5 | $44M | 1.1M | 41.03 | |
| Parabilis Medicines | 1.4 | $40M | 1.5M | 27.37 | |
| Edap Tms S A Sponsored Adr (FOCL) | 1.3 | $38M | 7.3M | 5.18 | |
| Globus Med Cl A (GMED) | 1.3 | $37M | 469k | 79.01 | |
| Arcus Biosciences Incorporated (RCUS) | 1.2 | $36M | 1.2M | 30.83 | |
| Syndax Pharmaceuticals (SNDX) | 1.2 | $36M | 1.6M | 21.86 | |
| Nurix Therapeutics (NRIX) | 1.2 | $36M | 1.5M | 24.26 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.2 | $35M | 1.2M | 28.88 | |
| Jade Biosciences Com New (JBIO) | 1.2 | $35M | 1.6M | 22.22 | |
| UnitedHealth (UNH) | 1.1 | $33M | 80k | 415.63 | |
| Avalo Therapeutics Com New (AVTX) | 1.1 | $31M | 1.7M | 18.48 | |
| Urogen Pharma (URGN) | 1.1 | $31M | 830k | 36.80 | |
| Mbx Biosciences (MBX) | 1.0 | $28M | 515k | 55.20 | |
| Palisade Bio (PALI) | 0.9 | $27M | 13M | 2.09 | |
| Pharvaris N V (PHVS) | 0.9 | $25M | 731k | 34.58 | |
| Organogenesis Hldgs (ORGO) | 0.8 | $25M | 10M | 2.43 | |
| Supernus Pharmaceuticals (SUPN) | 0.8 | $24M | 520k | 46.51 | |
| Procept Biorobotics Corp (PRCT) | 0.8 | $23M | 1.0M | 22.58 | |
| Tango Therapeutics (TNGX) | 0.8 | $22M | 709k | 31.26 | |
| Inhibikase Therapeutics Com New (IKT) | 0.8 | $22M | 11M | 2.03 | |
| Trevi Therapeutics (TRVI) | 0.8 | $22M | 1.2M | 18.65 | |
| BioMarin Pharmaceutical (BMRN) | 0.7 | $22M | 376k | 57.22 | |
| Livanova SHS (LIVN) | 0.7 | $21M | 255k | 82.23 | |
| Argenx Se Sponsored Adr (ARGX) | 0.6 | $19M | 20k | 927.77 | |
| Nuvectis Pharma (NVCT) | 0.6 | $18M | 1.0M | 18.39 | |
| Capricor Therapeutics Com New (CAPR) | 0.6 | $18M | 762k | 24.08 | |
| Edgewise Therapeutics (EWTX) | 0.6 | $18M | 451k | 40.63 | |
| Prelude Therapeutics (PRLD) | 0.6 | $18M | 3.4M | 5.33 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $16M | 267k | 60.36 | |
| C4 Therapeutics Com Stk (CCCC) | 0.5 | $16M | 3.4M | 4.67 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.5 | $16M | 246k | 63.95 | |
| Orthopediatrics Corp. (KIDS) | 0.5 | $14M | 732k | 19.13 | |
| Avalyn Pharmaceuticals Com Shs | 0.5 | $14M | 419k | 32.92 | |
| Biodesix (BDSX) | 0.5 | $13M | 586k | 22.55 | |
| Spyre Therapeutics Com New (SYRE) | 0.4 | $13M | 147k | 88.78 | |
| Twist Bioscience Corp (TWST) | 0.4 | $11M | 105k | 102.88 | |
| Vir Biotechnology (VIR) | 0.4 | $10M | 1.0M | 10.19 | |
| Alnylam Pharmaceuticals (ALNY) | 0.3 | $9.9M | 33k | 301.03 | |
| Immunovant (IMVT) | 0.3 | $9.7M | 252k | 38.53 | |
| Insmed Com Par $.01 (INSM) | 0.3 | $9.6M | 90k | 106.62 | |
| Septerna (SEPN) | 0.3 | $9.2M | 275k | 33.49 | |
| Sophia Genetics Sa Ordinary Shares (SOPH) | 0.3 | $9.0M | 1.6M | 5.77 | |
| Nektar Therapeutics Com New (NKTR) | 0.3 | $9.0M | 128k | 69.81 | |
| Mirum Pharmaceuticals (MIRM) | 0.3 | $8.8M | 75k | 117.07 | |
| CryoLife (AORT) | 0.3 | $8.7M | 388k | 22.47 | |
| Tandem Diabetes Care Com New (TNDM) | 0.3 | $8.7M | 575k | 15.09 | |
| Enliven Therapeutics (ELVN) | 0.3 | $8.4M | 166k | 50.75 | |
| Sionna Therapeutics (SION) | 0.3 | $7.8M | 178k | 43.99 | |
| Belite Bio Sponsored Ads (BLTE) | 0.3 | $7.8M | 51k | 153.99 | |
| Cerus Corporation (CERS) | 0.3 | $7.3M | 2.5M | 2.92 | |
| Silence Therapeutics Ads (SLN) | 0.2 | $6.9M | 630k | 10.98 | |
| Immunic Com New (IMUX) | 0.2 | $6.9M | 450k | 15.37 | |
| Adagio Therapeutics (IVVD) | 0.2 | $6.7M | 7.7M | 0.87 | |
| Merck & Co (MRK) | 0.2 | $6.4M | 50k | 128.50 | |
| Relmada Therapeutics (RLMD) | 0.2 | $5.8M | 842k | 6.92 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $5.7M | 107k | 53.67 | |
| Evolus (EOLS) | 0.2 | $5.7M | 822k | 6.94 | |
| Adlai Nortye Sponsored Ads (ANL) | 0.2 | $4.7M | 406k | 11.50 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.2 | $4.6M | 950k | 4.85 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.1 | $4.3M | 440k | 9.77 | |
| Context Therapeutics (CNTX) | 0.1 | $3.9M | 7.1M | 0.55 | |
| Pulmonx Corp (LUNG) | 0.1 | $3.6M | 2.8M | 1.30 | |
| Sab Biotherapeutics Com New (SABS) | 0.1 | $3.5M | 900k | 3.90 | |
| Tectonic Therapeutic (TECX) | 0.1 | $3.5M | 102k | 34.38 | |
| Axogen (AXGN) | 0.1 | $2.6M | 57k | 46.19 | |
| Satellos Bioscience (MSLE) | 0.1 | $2.4M | 314k | 7.78 | |
| Arrivent Biopharma (AVBP) | 0.1 | $1.7M | 50k | 34.74 | |
| Corcept Therapeutics Incorporated (CORT) | 0.1 | $1.7M | 20k | 86.95 | |
| Solid Biosciences Com New (SLDB) | 0.1 | $1.5M | 150k | 9.99 | |
| Veracyte (VCYT) | 0.1 | $1.5M | 25k | 58.73 | |
| Cullinan Oncology (CGEM) | 0.0 | $911k | 50k | 18.21 | |
| Inspiremd (NSPR) | 0.0 | $732k | 1.0M | 0.70 | |
| Genedx Holdings Corp Com Cl A (WGS) | 0.0 | $687k | 10k | 68.65 | |
| Iovance Biotherapeutics (IOVA) | 0.0 | $624k | 150k | 4.16 | |
| Larimar Therapeutics (LRMR) | 0.0 | $574k | 188k | 3.05 | |
| Cg Oncology (CGON) | 0.0 | $355k | 5.0k | 71.05 | |
| Quoin Pharmaceuticals Sponsored Ads (QNRX) | 0.0 | $352k | 73k | 4.84 | |
| Equillium (EQ) | 0.0 | $288k | 90k | 3.20 | |
| Natera (NTRA) | 0.0 | $272k | 1.0k | 271.45 | |
| Neogenomics Com New (NEO) | 0.0 | $146k | 10k | 14.59 |
